STERIS plc Stock-Based Compensation
STERIS plc (STE) reported Stock-Based Compensation of $12.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-07
- STERIS plc share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $12.80M, a 7.56% increase year-over-year.
- STERIS plc share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $12.90M, a 31.63% increase year-over-year.
- STERIS plc share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $15.70M, a 2.61% increase year-over-year.
- STERIS plc share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $21.20M, a 1.92% increase year-over-year.
- STERIS plc share-based payment arrangement, noncash expense for fiscal 2026 was $61.70M, a 7.49% increase from fiscal 2025.
- STERIS plc share-based payment arrangement, noncash expense for fiscal 2025 was $57.40M, a 1.59% increase from fiscal 2024.
- STERIS plc share-based payment arrangement, noncash expense for fiscal 2024 was $56.50M, a 45.05% increase from fiscal 2023.
- STERIS plc share-based payment arrangement, noncash expense for fiscal 2023 was $38.95M, a 32.45% decline from fiscal 2022.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $12.80M 10-Q · filed 2026-08-07 | $25.70M derived: sum of 2 quarters · filed 2026-08-07 | $41.40M derived: sum of 3 quarters · filed 2026-08-07 | $62.60M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $12.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $28.60M derived: sum of 2 quarters · filed 2026-05-29 | $49.80M derived: sum of 3 quarters · filed 2026-05-29 | $61.70M 10-K · filed 2026-05-29 | ||||
| 2025-12-31 | $15.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $36.90M derived: sum of 2 quarters · filed 2026-02-06 | $48.80M 10-Q · filed 2026-02-06 | $58.60M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-09-30 | $21.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $33.10M 10-Q · filed 2025-11-06 | $42.90M derived: sum of 3 quarters · filed 2026-08-07 | $58.20M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $11.90M 10-Q · filed 2026-08-07 | $21.70M derived: sum of 2 quarters · filed 2026-08-07 | $37.00M derived: sum of 3 quarters · filed 2026-08-07 | $57.80M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $9.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $25.10M derived: sum of 2 quarters · filed 2026-05-29 | $45.90M derived: sum of 3 quarters · filed 2026-05-29 | $57.40M 10-K · filed 2026-05-29 | $57.40M 10-K · filed 2025-05-29 | |||
| 2024-12-31 | $15.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $36.10M derived: sum of 2 quarters · filed 2026-02-06 | $47.60M 10-Q · filed 2026-02-06 | $47.61M 10-Q · filed 2025-02-07 | $56.51M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-09-30 | $20.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $32.30M 10-Q · filed 2025-11-06 | $32.27M 10-Q · filed 2024-11-07 | $41.21M derived: sum of 3 quarters · filed 2026-05-29 | $56.51M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-06-30 | $11.50M 10-Q · filed 2025-08-07 | $11.46M 10-Q · filed 2024-08-08 | $20.41M derived: sum of 2 quarters · filed 2026-05-29 | $35.70M derived: sum of 3 quarters · filed 2026-05-29 | $56.42M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-03-31 | $8.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $24.20M derived: sum of 2 quarters · filed 2026-05-29 | $44.92M derived: sum of 3 quarters · filed 2026-05-29 | $56.50M 10-K · filed 2026-05-29 | $56.53M 10-K · filed 2024-05-29 | |||
| 2023-12-31 | $15.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-07 | $36.01M derived: sum of 2 quarters · filed 2025-02-07 | $47.59M 10-Q · filed 2025-02-07 | $56.68M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-09-30 | $20.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $32.30M 10-Q · filed 2024-11-07 | $41.39M derived: sum of 3 quarters · filed 2025-05-29 | $50.73M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-06-30 | $11.58M 10-Q · filed 2024-08-08 | $20.67M derived: sum of 2 quarters · filed 2025-05-29 | $30.02M derived: sum of 3 quarters · filed 2025-05-29 | $41.57M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-03-31 | $9.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $18.44M derived: sum of 2 quarters · filed 2025-05-29 | $29.99M derived: sum of 3 quarters · filed 2025-05-29 | $38.95M 10-K · filed 2025-05-29 | ||||
| 2022-12-31 | $9.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $20.89M derived: sum of 2 quarters · filed 2024-02-08 | $29.86M 10-Q · filed 2024-02-08 | $39.61M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-09-30 | $11.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-07 | $20.51M 10-Q · filed 2023-11-07 | $30.26M derived: sum of 3 quarters · filed 2024-05-29 | $40.26M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-06-30 | $8.96M 10-Q · filed 2023-08-08 | $18.71M derived: sum of 2 quarters · filed 2024-05-29 | $28.71M derived: sum of 3 quarters · filed 2024-05-29 | $40.02M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-03-31 | $9.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | $19.75M derived: sum of 2 quarters · filed 2024-05-29 | $31.06M derived: sum of 3 quarters · filed 2024-05-29 | $57.66M 10-K · filed 2024-05-29 | ||||
| 2021-12-31 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-08 | $21.31M derived: sum of 2 quarters · filed 2023-02-08 | $47.91M 10-Q · filed 2023-02-08 | $53.95M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-09-30 | $11.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | $37.91M 10-Q · filed 2022-11-09 | $43.95M derived: sum of 3 quarters · filed 2023-05-26 | $49.98M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-06-30 | $26.60M 10-Q · filed 2022-08-08 | $32.64M derived: sum of 2 quarters · filed 2023-05-26 | $38.66M derived: sum of 3 quarters · filed 2023-05-26 | $46.60M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-03-31 | $6.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $12.06M derived: sum of 2 quarters · filed 2023-05-26 | $20.00M derived: sum of 3 quarters · filed 2023-05-26 | $25.97M 10-K · filed 2023-05-26 | ||||
| 2020-12-31 | $6.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-09 | $13.96M derived: sum of 2 quarters · filed 2022-02-09 | $19.92M 10-Q · filed 2022-02-09 | $24.87M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-09-30 | $7.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08 | $13.90M 10-Q · filed 2021-11-08 | $18.85M derived: sum of 3 quarters · filed 2022-05-31 | $24.44M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-06-30 | $5.96M 10-Q · filed 2021-08-09 | $10.91M derived: sum of 2 quarters · filed 2022-05-31 | $16.50M derived: sum of 3 quarters · filed 2022-05-31 | $24.24M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-03-31 | $4.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | $10.54M derived: sum of 2 quarters · filed 2022-05-31 | $18.27M derived: sum of 3 quarters · filed 2022-05-31 | $23.81M 10-K · filed 2022-05-31 | ||||
| 2019-12-31 | $5.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09 | $13.32M derived: sum of 2 quarters · filed 2021-02-09 | $18.86M 10-Q · filed 2021-02-09 | $24.47M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-09-30 | $7.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-06 | $13.28M 10-Q · filed 2020-11-06 | $18.88M derived: sum of 3 quarters · filed 2021-05-28 | $24.30M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-06-30 | $5.54M 10-Q · filed 2020-08-07 | $11.14M derived: sum of 2 quarters · filed 2021-05-28 | $16.56M derived: sum of 3 quarters · filed 2021-05-28 | $24.27M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-03-31 | $5.61M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | $11.03M derived: sum of 2 quarters · filed 2021-05-28 | $18.73M derived: sum of 3 quarters · filed 2021-05-28 | $23.96M 10-K · filed 2021-05-28 | ||||
| 2018-12-31 | $5.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $13.12M derived: sum of 2 quarters · filed 2020-02-10 | $18.36M 10-Q · filed 2020-02-10 | |||||
| 2018-09-30 | $7.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | $12.94M 10-Q · filed 2019-11-07 | ||||||
| 2018-06-30 | $5.24M 10-Q · filed 2019-08-07 | |||||||
| 2018-03-31 | $22.19M 8-K · filed 2021-02-09 | |||||||
| 2017-03-31 | $18.79M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |